Table 1.

Patient characteristics

CharacteristicNo. (%)
Total patients15
Age (y)
    Median64
    Range37-69
Sex
    Female5 (33)
    Male10 (67)
ECOG performance status
    06 (40)
    19 (60)
Grade of neuroendocrine carcinoma
    Well differentiated11 (73)
    Moderately differentiated4 (27)
Primary sites
    Small bowel6 (40)
    Colorectal2 (13)
    Lung2 (13)
    Pancreas1 (7)
    Unknown4 (27)
Metastatic sites
    Liver alone2 (13)
    Liver and lymph nodes or bones5 (33)
    Liver, lymph nodes, and bones7 (47)
Carcinoid syndrome/concurrent octreotide therapy
    Present11 (73)
    Absent4 (27)
Prior treatment
    Debulking or palliative surgery7 (47)
    Hepatic artery chemoembolization7 (47)
    Systemic chemotherapy3 (20)
    Radiation2 (13)
    Immunotherapy1 (7)
Baseline elevation of serum tumor markers
    Pancreastatin14 (93)
    Calcitonin2 (13)
    Gastrin2 (13)
    Glucagon1 (7)
    Neurotensin1 (7)
    Pancreatic polypeptide1 (7)
  • Abbreviation: ECOG, Eastern Cooperative Oncology Group.